Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers (Girasol)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00925288
Recruitment Status :
First Posted : June 22, 2009
Results First Posted : October 11, 2012
Last Update Posted : October 11, 2012
Johns Hopkins Bloomberg School of Public Health
Merck Sharp & Dohme Corp.
NGO Via Libre
Universidad Peruana Cayetano Heredia
Information provided by (Responsible Party):
Neal Halsey, Johns Hopkins Bloomberg School of Public Health
FSWs 18-26 years of age were recruited in person between August 28, 2009 and March 3, 2010 from 49 different sex locales in Lima, Peru by trained medical staff and 8 health promoters. If they fulfilled inclusion criteria, women were asked to report to the study clinic for completion of surveys, vaccination, Pap smears, and counseling.
Some eligible participants provided a false phone number, did not show up for their study appointment, refused to use birth control when receiving vaccine doses, and reported not having time to participate in the study. After the survey and Pap smear, vaccination was the final step in study enrollment.
Duration: 0,2,6 months each dose Do...
Duration: 0,3,6 months each dose Do...
Duration: 0,2,6 months each dose Dose form: standard injectable HPV4 vaccine Groups: FSWs 18-26 years of age
Duration: 0,3,6 months each dose Dose form: standard injectable HPV4 vaccine Groups: FSWs 18-26 years of age